Both in Pharmaceuticals
Alnylam Pharmaceuticals vs Royalty Pharma
Over the past year ALNY returned −63.8% and RPRX returned +79.0%; their daily moves had a correlation of 0.19.
ALNY −63.8% RPRX +79.0%Growth of $1, one year, split-adjusted
| Metric | ALNY | RPRX |
|---|---|---|
| Price | $165.00 | $67.18 |
| Market cap | $22.10B | $29.91B |
| Today | −5.17% | +1.90% |
| 1 month | −28.6% | +16.6% |
| 6 months | −44.3% | +35.8% |
| Year to date | −58.5% | +73.9% |
| 1 year | −65.7% | +83.2% |
| Revenue growth (YoY) | +16.7% | +16.5% |
| Gross margin | 75.2% | 100.0% |
| Net margin | 148.6% | 2.7% |
| P/E (TTM) | 8.1× | 36.7× |
| Price / sales | 4.4× | 11.8× |
| Net cash | $2.57B | -$8.23B |
| Dividend yield | — | 1.40% |
| Volatility (60d) | 72.5% | 24.9% |
| Short % of float | 4.9% | 2.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).